[go: up one dir, main page]

WO1996009391A3 - Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 - Google Patents

Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 Download PDF

Info

Publication number
WO1996009391A3
WO1996009391A3 PCT/EP1995/003758 EP9503758W WO9609391A3 WO 1996009391 A3 WO1996009391 A3 WO 1996009391A3 EP 9503758 W EP9503758 W EP 9503758W WO 9609391 A3 WO9609391 A3 WO 9609391A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequences
structural
protein
antigens
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1995/003758
Other languages
French (fr)
Other versions
WO1996009391A2 (en
Inventor
Hans Wolf
Poblotzki Andreas Von
Susanne Modrow
Andreas Gigler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP95934630A priority Critical patent/EP0783580A2/en
Priority to AU36985/95A priority patent/AU3698595A/en
Publication of WO1996009391A2 publication Critical patent/WO1996009391A2/en
Publication of WO1996009391A3 publication Critical patent/WO1996009391A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

DNA sequences of the human parvovirus B19 genome coding for the non-structural protein, recombinant DNA molecules containing such sequences, antigens coded within these sDNA sequences of the parvovirus B19 genome coding for the non-structural protein sequences, production of those antigens, generation of antibodies or antibody related molecules directed to such antigens, use of these sequences, antigens, antibodies or antibody related molecules for diagnostic, therapeutic or vaccination purposes.
PCT/EP1995/003758 1994-09-22 1995-09-22 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 Ceased WO1996009391A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP95934630A EP0783580A2 (en) 1994-09-22 1995-09-22 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
AU36985/95A AU3698595A (en) 1994-09-22 1995-09-22 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94114973.4 1994-09-22
EP94114973 1994-09-22

Publications (2)

Publication Number Publication Date
WO1996009391A2 WO1996009391A2 (en) 1996-03-28
WO1996009391A3 true WO1996009391A3 (en) 1996-08-29

Family

ID=8216310

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/003758 Ceased WO1996009391A2 (en) 1994-09-22 1995-09-22 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19

Country Status (3)

Country Link
EP (1) EP0783580A2 (en)
AU (1) AU3698595A (en)
WO (1) WO1996009391A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771751B1 (en) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris ERYTHROVIRUS AND ITS APPLICATIONS
US6642033B1 (en) * 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
KR100944674B1 (en) 2001-06-28 2010-03-04 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 Diagnostic analysis of parvovirus Ｂ19
WO2003020742A1 (en) 2001-08-31 2003-03-13 Gen-Probe Incorporated Assay for detection of human parvovirus b19 nucleic acid
EP1799856A4 (en) * 2004-09-10 2009-03-04 Focus Diagnostics Inc Methods and compositions for detecting erythrovirus genotypes
AU2010217928B2 (en) 2009-02-26 2013-06-06 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
WO2012117382A1 (en) * 2011-03-03 2012-09-07 Novartis Ag Method for detecting parvovirus antigen
CA2841531C (en) 2011-07-15 2021-11-09 Gen-Probe Incorporated Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays
CN103849630B (en) * 2014-03-17 2016-01-13 北京英诺特生物技术有限公司 A kind of recombinant human assays for parvovirus B 19 albumen and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07147986A (en) * 1992-09-24 1995-06-13 Denki Kagaku Kogyo Kk Human parvovirus gene, polypeptides encoded thereby and uses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07147986A (en) * 1992-09-24 1995-06-13 Denki Kagaku Kogyo Kk Human parvovirus gene, polypeptides encoded thereby and uses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREAS VON POBLOTZKI ET AL.: "Antibodies to parvovirus B19 NS-1 protein in infected individuals", JOURNAL OF GENERAL VIROLOGY, vol. 76, no. 3, March 1995 (1995-03-01), READING GB, pages 519 - 527, XP002005738 *
KEIYA OZAWA ET AL.: "The gene encoding the nonstructural protein of B19 (human) Parvovirus may be lethal in transfected cells", JOURNAL OF VIROLOGY, vol. 62, no. 8, August 1988 (1988-08-01), pages 2884 - 2889, XP002005736 *
ROSEMARY O. SHADE ET AL.: "Nucleotide sequence and genome organization of human Parvovirus B19 isolated from the serum of a child during aplastic crisis", JOURNAL OF VIROLOGY, vol. 58, no. 3, June 1986 (1986-06-01), pages 921 - 936, XP002005737 *

Also Published As

Publication number Publication date
AU3698595A (en) 1996-04-09
WO1996009391A2 (en) 1996-03-28
EP0783580A2 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
ATE229072T1 (en) ISOLATED NUCLEIC ACID MOLECULE ENCODING THE PRECURSOR OF THE ANTIGEN MAGE-3 RESPONSIBLE FOR TUMOR REJECTION AND ITS USE
DE69637642D1 (en) AND COMBINED COMPOSITIONS AND THEIR USE
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
WO1998040483A3 (en) 28 human secreted proteins
ATE205254T1 (en) TRANSFORMING GROWTH FACTOR ALPHA H1
CY1111950T1 (en) 32 HUMAN EXTRACTED PROTEINS
WO2001012776A3 (en) 18 human secreted proteins
WO1996009391A3 (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
WO2000077026A8 (en) 49 human secreted proteins
DE69019359D1 (en) HUMAN PARVOVIRUS B19 PROTEINS AND VIRUS-LIKE PARTICLES, THEIR PRODUCTION AND THEIR USE IN DIAGNOSTIC TESTS AND VACCINES.
WO2001062891A3 (en) 207 human secreted proteins
WO2000063230A3 (en) 49 human secreted proteins
EP1042342A4 (en) 53 human secreted proteins
DK0629238T3 (en) Autotaxin: Motility-stimulating protein useful for cancer diagnosis and therapy
WO2000061774A3 (en) Bone morphogenic proteins
WO2001012775A8 (en) 25 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
WO2000043495A3 (en) 33 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
WO1999009177A3 (en) Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
BR9911609A (en) Moraxella catarrhalis proteins and genes, antigens, antibodies and uses
WO2000061596A8 (en) 50 human secreted proteins
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1995934630

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995934630

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995934630

Country of ref document: EP